Article
IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease.
Diabetic medicine : a journal of the British Diabetic Association - 1 Feb 2006
Hiromatsu Y, Mukai T, Kaku H, Miyake I, Ichimura M, Fukutani T, Nakayama H, Takata K, Imamura Y, Shoji S, Yamada K, Koda Y, Bednarczuk T
Abstract excerpt
AIMS: This study aimed to investigate whether interleukin-18 (IL-18) gene polymorphisms are associated with the development of antibody against the 65-kDa isoform of recombinant human glutamic acid decarboxylase (GAD65Ab) in patients with Graves' disease. METHODS: A total of 398 unrelated Japanese patients with Graves' disease, with and without GAD65Ab, were recruited. Three single nucleotide polymorphisms in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
